EV/EBITDA:
-7.47+0.23(+2.99%)Summary
- As of today (August 1, 2025), ELVN EV/EBITDA is -7.47, with a rise of +0.23 (+2.99%) during the most recent trading session on July 31, 2025.
- Over the past year, ELVN EV/EBITDA has increased by +4.33 (+36.69%).
- ELVN EV/EBITDA is now -70.55% below its all-time high of -4.38.
Performance
ELVN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ELVN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +3.0% | -3.0% | -2.6% |
| 1 m1 month | +7.0% | -7.0% | -6.2% |
| 3 m3 months | +0.8% | -0.8% | -0.7% |
| 6 m6 months | +17.6% | -13.1% | -13.9% |
| ytdytd | +20.3% | -15.9% | -16.4% |
| 1 y1 year | +36.7% | -28.4% | -28.7% |
| 5 y5 years | - | - | -6.8% |
ELVN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -7.47 | at high | -9.49 | +21.3% |
| 3 m | 3-month | -6.21 | -20.3% | -9.49 | +21.3% |
| 6 m | 6-month | -5.73 | -30.4% | -9.49 | +21.3% |
| 1 y | 1-year | -5.73 | -30.4% | -13.42 | +44.3% |
| 3 y | 3-year | -4.38 | -70.5% | -23.53 | +68.3% |
| 5 y | 5-year | -4.38 | -70.5% | -23.53 | +68.3% |
| alltime | all time | -4.38 | -70.5% | -23.53 | +68.3% |
ELVN EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -7.47(-20.3%) |
| Date | Value |
|---|---|
| 2024 | -9.37(+65.3%) |
| 2023 | -5.67 |
FAQ
- What is Enliven Therapeutics, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Enliven Therapeutics, Inc.?
- What is ELVN EV/EBITDA year-to-date change?
- What is Enliven Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Enliven Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of ELVN is -7.47
What is the all time high EV/EBITDA for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high EV/EBITDA is -4.38
What is ELVN EV/EBITDA year-to-date change?
Enliven Therapeutics, Inc. EV/EBITDA has changed by +1.90 (+20.28%) since the beginning of the year
What is Enliven Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, ELVN EV/EBITDA has changed by +4.33 (+36.69%)